Furthermore, compared to cognitively normal individuals, those with either with self-reported obstructive sleep apnea (OSA) diagnosis [14] or physician-diagnosed OSA [15] developed more Alzheimer’s disease biomarkers, such as amyloid-beta plaques or tau proteins, over time compared to those without OSA. Here, MAPT is linked to obstructive sleep apnea syndrome.